SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
Authors
Keywords
-
Journal
IMMUNITY
Volume 56, Issue 4, Pages 879-892.e4
Publisher
Elsevier BV
Online
2023-03-23
DOI
10.1016/j.immuni.2023.02.017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19
- (2022) Naoki Kaneko et al. CLINICAL IMMUNOLOGY
- The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
- (2022) Marios Koutsakos et al. IMMUNITY
- Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil
- (2022) Hyon-Xhi Tan et al. JOURNAL OF IMMUNOLOGY
- COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
- (2022) Freja C M Kirsebom et al. LANCET INFECTIOUS DISEASES
- Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
- (2022) Kathleen M. Wragg et al. NATURE IMMUNOLOGY
- SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells
- (2022) Anastasia A. Minervina et al. NATURE IMMUNOLOGY
- Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
- (2022) Olha Puhach et al. NATURE MEDICINE
- Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant
- (2022) Ai-ris Y. Collier et al. Science Translational Medicine
- Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
- (2022) Adam S Lauring et al. BMJ-British Medical Journal
- SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity
- (2022) Joey Ming Er Lim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation
- (2022) Matthias Reinscheid et al. Nature Communications
- Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
- (2022) Hassen Kared et al. Nature Communications
- The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses
- (2022) Sungmin Jung et al. Cell Reports
- CD8 T Cells Contribute to Vaccine Protection Against SARS-CoV-2 in Macaques
- (2022) Jinyan Liu et al. Science Immunology
- SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
- (2022) Antonio Bertoletti et al. IMMUNITY
- Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization
- (2022) Antonio Bertoletti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- T cell immunity to COVID-19 vaccines
- (2022) E. John Wherry et al. SCIENCE
- Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity
- (2022) Martin J. Scurr et al. Nature Communications
- Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study
- (2022) Miguel Garcia-Knight et al. PLoS Pathogens
- Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
- (2022) Sarah A. Buchan et al. JAMA Network Open
- Mapping and role of T cell response in SARS-CoV-2–infected mice
- (2021) Zhen Zhuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
- (2021) Adam K. Wheatley et al. Nature Communications
- CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses
- (2021) Katie E. Lineburg et al. IMMUNITY
- CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity
- (2021) Thi H.O. Nguyen et al. IMMUNITY
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- SARS‐CoV‐2‐specific CD8 + T‐cell responses and TCR signatures in the context of a prominent HLA‐A*24:02 allomorph
- (2021) Louise C Rowntree et al. IMMUNOLOGY AND CELL BIOLOGY
- Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine
- (2021) Valerie Oberhardt et al. NATURE
- SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
- (2021) Fiona Tea et al. PLOS MEDICINE
- SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
- (2021) Philip A. Mudd et al. CELL
- Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
- (2021) Po Ying Chia et al. CLINICAL MICROBIOLOGY AND INFECTION
- Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
- (2021) Anika Singanayagam et al. LANCET INFECTIOUS DISEASES
- An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
- (2021) Yanchun Peng et al. NATURE IMMUNOLOGY
- REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
- (2021) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination
- (2021) Katharina Wild et al. Nature Communications
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens
- (2020) Jasper Fuk-Woo Chan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones
- (2020) Anastasia A Minervina et al. eLife
- Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
- (2020) Jennifer A. Juno et al. NATURE MEDICINE
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19
- (2020) Benjamin J. Meckiff et al. CELL
- Suboptimal SARS-CoV-2−specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype
- (2020) Jennifer R. Habel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19
- (2020) Min-Seok Rha et al. IMMUNITY
- With a Little Help from T Follicular Helper Friends: Humoral Immunity to Influenza Vaccination
- (2019) Marios Koutsakos et al. JOURNAL OF IMMUNOLOGY
- Improved methods for predicting peptide binding affinity to MHC class II molecules
- (2018) Kamilla Kjaergaard Jensen et al. IMMUNOLOGY
- Circulating T FH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity
- (2018) Marios Koutsakos et al. Science Translational Medicine
- Distinct T helper cell dependence of memory B-cell proliferation versus plasma cell differentiation
- (2017) Franziska Zabel et al. IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started